First human tests begin for new antibiotic helper drug
NCT ID NCT02674347
Summary
This early-stage study aimed to check if multiple doses of an experimental drug called zidebactam are safe for healthy people and to see how the body processes it. The drug is being developed to help fight tough bacterial infections. A small group of 21 healthy adults received either the drug or a placebo to compare the effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Quintiles
Overland Park, Kansas, 66211, United States
Conditions
Explore the condition pages connected to this study.